Medicine & Life Sciences
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
100%
Protein-Tyrosine Kinases
61%
Leukemia, Myeloid, Chronic Phase
37%
Salvage Therapy
32%
bosutinib
22%
Oncogene Fusion
22%
ponatinib
22%
Chromosomes
21%
TYK2 Kinase
20%
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide
19%
Dasatinib
18%
Philadelphia Chromosome
17%
Genetic Translocation
17%
Therapeutics
15%
Imatinib Mesylate
15%
Gene Fusion
15%
Oncogene Proteins
15%
Multigene Family
14%
Allogeneic Cells
14%
Stem Cell Transplantation
14%
United States Food and Drug Administration
13%
Leukemia
11%
Comorbidity
10%
Pharmacology
9%
Clinical Trials
8%
Mutation
7%
Survival
7%
Incidence
6%
Neoplasms
4%